Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Levi Garraway
Dana Farber Cancer Inst, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Foundation Medicine
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
The goal of this federally funded research is to create and apply computational biology algorithms that model clinical resistance with genomic data to inform subsequtent treatment strategies, which will facilitate a focused and comprehensive assessment of ADT2 resistance in the neoadjuvant and metastatic CRPC settings, explain genetic resistance to ADT2 in prostate cancer and define subsequent therapeutic strategies.
Resistance to Emerging Androgen Deprivation Therapies in Prostate Cancer
Emerging therapies have improved clinical outcomes for patients with metastatic prostate cancer, although most patients develop resistance to these agents and cannot be cured. Resistance mechanisms may be driven by genetic changes in the tumors of these patients, which may be targetable with other therapies. This project aims to dissect clinical resistance to these agents and determine subsequent treatment approaches for this large patient population.
Filed on September 18, 2014.
Tell us what you know about Levi Garraway's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Levi Garraway”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Levi Garraway | Dana Farber Cancer Inst | Conflict of Interest | Foundation Medicine | $80,000 - $99,999 |
| Levi Garraway | Dana Farber Cancer Inst | Conflict of Interest | Foundation Medicine | >$600,000 |
| Levi Garraway | Harvard Medical School | Conflict of Interest | Foundation Medicine, Inc. | $80,000 - $99,999 |
| Levi Garraway | Massachusetts General Hospital | Conflict of Interest | Foundation Medicine | $80,000 - $99,999 |
| Levi Garraway | Massachusetts General Hospital | Conflict of Interest | Foundation Medicine | Value cannot be readily determined |
| Levi Garraway | Harvard Medical School | Conflict of Interest | Foundation Medicine, Inc. | >$600,000 |
| Levi Garraway | Dana Farber Cancer Inst | Conflict of Interest | Foundation Medicine | $60,000 - $79,999 |
| Levi Garraway | Dana Farber Cancer Inst | Conflict of Interest | Foundation Medicine | $60,000 - $79,999 |
| Levi Garraway | Dana Farber Cancer Inst | Conflict of Interest | Foundation Medicine | >$600,000 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.